Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology reports developments in digital orthodontics and restorative dentistry through its Invisalign System of clear aligners, iTero intraoral scanners, exocad CAD/CAM software and the Align Digital Platform. Company news commonly covers product and workflow updates for clear-aligner treatment planning, intraoral scanning, 3D visualization and digitally connected dental practices.
Recurring updates also include quarterly and annual operating results, clear-aligner shipment and channel trends, regional demand, foreign-exchange effects, stock repurchase activity, financial-conference participation and governance or shareholder-voting matters. Other announcements describe clinical education, professional collaborations and access-to-care initiatives involving orthodontists, general practitioner dentists and dental research organizations.
Align Technology (NASDAQ: ALGN) has announced that NFL quarterback Patrick Mahomes has joined the Invisalign Smile Squad as a brand ambassador. Through a multi-year agreement, Mahomes will share his personal experience with Invisalign clear aligners through a multi-channel campaign.
The Invisalign Smile Squad, launched in 2017, is part of Align's strategy to increase awareness and educate consumers about Invisalign treatment benefits. The program collaborates with regional and global influencers who share their Invisalign treatment journeys across social media platforms including TikTok, Instagram, YouTube, and Snapchat.
Mahomes, the Kansas City Chiefs quarterback, chose Invisalign aligners over traditional braces, citing his focus on optimizing performance and health as an athlete.
Align Technology (ALGN) has announced it will release its fourth quarter and 2024 financial results on Wednesday, February 5, 2025, after market close at 4:00 p.m. ET. The company will host a conference call at 4:30 p.m. ET to discuss the results, which will also be available as a live audio webcast.
The company has also revealed its tentative earnings release dates for fiscal 2025: Q1 on April 30, Q2 on July 30, and Q3 on October 29. Align Technology is a global medical device company specializing in the Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, serving over 271,000 doctor customers and having treated approximately 18.9 million patients with the Invisalign System over 27 years.
Align Technology has received CE Mark in Europe and MHRA registration in the UK for its Invisalign® Palatal Expander System. This innovative 3D-printed device offers a removable alternative to traditional palatal expanders for treating narrow maxilla in patients with primary, mixed, or permanent dentition. Combined with Invisalign First™ aligners, it provides doctors with a complete early intervention treatment solution for both skeletal and dental arch expansion. The system is approved for broad patient applicability, including growing children, teens, and adults. The product is expected to be commercially available across EMEA in Q1 2025.
Align Technology hosted its 2024 Invisalign Ortho Summit, a premier educational event focused on digital practice transformation and treatment experiences. The three-day summit attracted over 1,000 doctors and practice team members who participated in hands-on experiences, clinical training, and practice growth strategies. The event showcased the Align Digital Platform and innovations including the Invisalign System with mandibular advancement, Invisalign Palatal Expander System, and Invisalign First. The Innovation Hub demonstrated digital tools and resources, while breakout sessions covered topics from clinical best practices to patient experience optimization.
Align Technology has launched its 2025 Annual Research Award Program, offering up to $300,000 in funding for university faculty conducting dental and orthodontic research globally. The program, which has funded approximately $3.75 million in research since 2010, will distribute twelve one-year awards of up to $25,000 each across Americas, EMEA, and APAC regions. Full-time and part-time faculty at universities where Invisalign® treatment or iTero™ scanner is available can apply until March 7, 2025, with winners announced by June 2, 2025.
Align Technology (ALGN) has announced its participation in four upcoming financial conferences in November and December 2024. The company will present at the UBS Global Healthcare Conference in Rancho Palos Verdes, the Jefferies London Healthcare Conference in England, the Piper Sandler Healthcare Conference in New York, and the Evercore HealthCONx Conference in Coral Gables. CFO John Morici will attend all events, with CEO Joseph Hogan joining for the London conference.
All presentations will be accessible via webcast through Align's Investor Relations website, with recordings available for approximately three months afterward. Align Technology is known for its Invisalign System, iTero intraoral scanners, and exocad CAD/CAM software, serving over 271,000 doctors globally.
Align Technology (ALGN) has announced plans to repurchase $275 million of its common stock through open market repurchases under its $1.0 billion stock repurchase program approved in January 2023. The repurchases will be executed via a Rule 10b5-1 trading plan and are expected to complete by January 2025, funded by cash on hand. As of September 30, 2024, Align had approximately 74.8 million shares outstanding and $1,041.9 million in cash and cash equivalents. The company cites strong balance sheet and cash flow generation as drivers for this decision.
Align Technology (ALGN) announced Frank Quinn will rejoin as Executive Vice President and Managing Director of the Americas region, reporting to CEO Joe Hogan. This appointment comes as part of a global organizational restructuring, which eliminates the position of Raj Pudipeddi, who will leave in Q4 2024. Quinn returns to Align after serving as Chief Revenue Officer at LightForce Orthodontics. During his previous 9-year tenure at Align, he held various leadership positions including VP and General Manager of the United States. Quinn brings extensive experience in orthodontics industry growth, strategy, and revenue management.
Align Technology (ALGN) reported Q3'24 total revenues of $977.9 million, up 1.8% year-over-year but down 4.9% sequentially. Clear Aligner revenues decreased 1.0% year-over-year to $786.8 million, while Imaging Systems and CAD/CAM Services revenues grew 15.6% to $191.0 million. The company achieved a GAAP operating margin of 16.6% and non-GAAP operating margin of 22.1%. Q3'24 net income was $116.0 million ($1.55 per diluted share). The company announced plans to repurchase up to $275.0 million of common stock starting Q4'24 and implemented a global restructuring plan with expected charges of approximately $30 million.
Align Technology (NASDAQ: ALGN) has announced the release of an enhanced version of Invisalign Smile Architect software with Multiple Treatment Plans functionality. This innovation allows doctors to compare orthodontic-only and ortho-restorative treatment plans side-by-side within the ClinCheck® treatment planning software. The software integrates with the Align Digital Platform and enables doctors to demonstrate treatment simulations using iTero scanners during office visits. The new feature includes tools like facial lines, tooth mass analysis, and in-face visualizations. The software is expected to be available to Invisalign trained doctors in Q4 2024.